AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 May 2013 07:00 AM
RNS
Acquires Omthera Pharmaceuticals
14 May 2013 02:00 PM
RNS
Director/PDMR Shareholding
08 May 2013 02:00 PM
RNS
Director/PDMR Shareholding
08 May 2013 02:00 PM
RNS
Director/PDMR Shareholding
02 May 2013 01:00 PM
RNS
Director/PDMR Shareholding
01 May 2013 03:00 PM
RNS
Director/PDMR Shareholding
01 May 2013 02:00 PM
RNS
Total Voting Rights
29 Apr 2013 03:00 PM
RNS
Director/PDMR Shareholding
29 Apr 2013 03:00 PM
RNS
Director/PDMR Shareholding
25 Apr 2013 05:50 PM
RNS
Result of AGM
25 Apr 2013 07:00 AM
RNS
1st Quarter Results
24 Apr 2013 09:00 AM
RNS
Notice of Results
05 Apr 2013 07:00 AM
RNS
Top-line results from OSKIRA-1 phase III study
03 Apr 2013 04:00 PM
RNS
Director/PDMR Shareholding
03 Apr 2013 04:00 PM
RNS
Director/PDMR Shareholding
02 Apr 2013 04:00 PM
RNS
Total Voting Rights
02 Apr 2013 02:00 PM
RNS
Director/PDMR Shareholding
02 Apr 2013 07:00 AM
RNS
US court says one PULMICORT patent invalid
27 Mar 2013 02:30 PM
RNS
Director/PDMR Shareholding
27 Mar 2013 02:30 PM
RNS
Director/PDMR Shareholding
26 Mar 2013 03:13 PM
RNS
Director/PDMR Shareholding
26 Mar 2013 07:00 AM
RNS
Filing of Annual Report on Form 20-F with SEC
25 Mar 2013 11:38 AM
RNS
Annual Financial Report
25 Mar 2013 07:00 AM
RNS
AstraZeneca settles over Crestor patent
21 Mar 2013 07:00 AM
RNS
AstraZeneca announces agreement with Moderna
21 Mar 2013 07:00 AM
RNS
AstraZeneca partners Karolinska Institute
21 Mar 2013 07:00 AM
RNS
AstraZeneca outlines growth strategy
18 Mar 2013 01:00 PM
RNS
AstraZeneca to establish strategic R&D centres
14 Mar 2013 10:00 AM
RNS
Block Listing Application
05 Mar 2013 07:00 AM
RNS
Australian court holds crestor patents invalid
01 Mar 2013 04:00 PM
RNS
Total Voting Rights
27 Feb 2013 10:00 AM
RNS
Director/PDMR Shareholding
27 Feb 2013 10:00 AM
RNS
Director/PDMR Shareholding
27 Feb 2013 10:00 AM
RNS
Director/PDMR Shareholding
27 Feb 2013 10:00 AM
RNS
Director/PDMR Shareholding
01 Feb 2013 04:00 PM
RNS
Total Voting Rights
31 Jan 2013 07:00 AM
RNS
Final Results
31 Jan 2013 07:00 AM
RNS
Final Results
30 Jan 2013 09:00 AM
RNS
Notice of Results
15 Jan 2013 01:00 PM
RNS
Announces changes to Senior Executive Team
02 Jan 2013 04:00 PM
RNS
Total Voting Rights
28 Dec 2012 03:58 PM
RNS
Director/PDMR Shareholding
14 Dec 2012 05:56 PM
RNS
CRESTOR US Patent Upheld
13 Dec 2012 02:59 PM
RNS
Top-line results of OSKIRA-4
07 Dec 2012 02:30 PM
RNS
Director/PDMR Shareholding
06 Dec 2012 02:30 PM
RNS
Director/PDMR Shareholding
03 Dec 2012 03:00 PM
RNS
Total Voting Rights
03 Dec 2012 03:00 PM
RNS
Blocklisting Interim Review
22 Nov 2012 02:30 PM
RNS
Director/PDMR Shareholding
21 Nov 2012 02:30 PM
RNS
Director/PDMR Shareholding

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings